AstraZeneca has been talking about the importance of expanding its network of collaborations at the JPMorgan healthcare conference in San Francisco.
Blogging from the meeting, Shaun Grady, vice president of strategic partnering and business development at the Anglo-Swedish drugmaker, noted that AstraZeneca and its MedImmune unit have a team of 60 “scouting for opportunities that fit our therapeutic and commercial focus”. He added that the firm has scheduled a record number of meetings at the event, approximately 320 in total.
{iframe}http://www.pharmatimes.com/Article/13-01-10/AstraZeneca_seeking_out_more_alliances.aspx{/iframe}